When Stable Vitiligo Turns to Surgery

Why Surgery Is Only Considered Once Vitiligo Is Stable

Vitiligo is an autoimmune condition in which the immune system destroys melanocytes, the pigment-producing cells in skin, leaving depigmented white patches that can appear at any age 2Ref 2National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024).Vitiligo.Vitiligo is a chronic autoimmune disorder in which melanocytes are destroyed, causing depigmented patches, with no cure but treatments that can stabilize and repigment skin; basis for the definitional framing and for why surgery requires melanocyte-destroying activity to have quieted first.. Surgical repigmentation techniques move melanocytes from unaffected skin to a depigmented patch, and that only works if the immune activity destroying melanocytes in the area has quieted down, because transplanting new pigment cells into skin that's still actively losing pigment generally fails.

Someone with unstable vitiligo, patches still spreading or new ones appearing, generally isn't a candidate yet; that activity needs to settle, sometimes with the help of medical treatment, before grafting is even on the table. Stability is usually judged over a period of months without new patches appearing or existing patches enlarging, sometimes supported by a trial period of medical treatment first to confirm the disease has genuinely settled rather than assuming it from appearance alone.

What Counts as a Candidate for Vitiligo Surgery

A look at what actually repigments vitiligo now typically starts with narrowband UVB phototherapy or topical medication, and surgery is generally reserved for stable patches that haven't responded adequately to either over a reasonable trial period, particularly in cosmetically sensitive areas like the face or hands 1Ref 1Bae JM, Jung HM, Hong BY, et al. (2017).Phototherapy for Vitiligo: A Systematic Review and Meta-analysis.Narrowband UVB phototherapy produces meaningful repigmentation in vitiligo, with response increasing over months of treatment; basis for phototherapy as a first-line treatment tried before surgery and as a common adjunct used to help grafts repigment surrounding skin.3Ref 3Rosmarin D, Passeron T, Pandya AG, et al. (2022).Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.Topical ruxolitinib cream produces significantly greater facial and total-body repigmentation than vehicle in nonsegmental vitiligo; basis for ruxolitinib as a treatment tried before surgery and used as a post-graft adjunct to support repigmentation.. Segmental vitiligo, a form that affects one area or one side of the body and tends to stabilize faster than the more common widespread form, is often considered a better surgical candidate for exactly that reason.

Someone whose vitiligo continues appearing in new areas, the more diffuse, symmetric form of the disease, generally isn't a surgical candidate yet regardless of how bothersome existing patches are. The timing constraint is about biology, not preference.

The Techniques: Moving Pigment From One Place to Another

Several surgical techniques share the same basic idea, transplanting melanocytes or small pieces of pigmented skin from an unaffected donor area into a stable, depigmented recipient area, but differ in how the tissue is harvested and prepared 2Ref 2National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024).Vitiligo.Vitiligo is a chronic autoimmune disorder in which melanocytes are destroyed, causing depigmented patches, with no cure but treatments that can stabilize and repigment skin; basis for the definitional framing and for why surgery requires melanocyte-destroying activity to have quieted first.. Punch grafting transplants small round pieces of pigmented skin into matching holes made in the depigmented area, while suction blister grafting lifts a thin sheet of the top skin layer using vacuum pressure rather than a punch tool.

A newer approach separates melanocytes and keratinocytes from a small donor sample into a cell suspension, then spreads that suspension over a larger recipient area than the donor site alone could cover, useful when the area needing repigmentation is larger than what a punch or blister technique could practically supply from the donor skin.

Each technique involves a trade-off between how much area a small donor site can realistically cover and how much control the surgeon has over exactly where pigment ends up. Punch grafting is more labor-intensive per square centimeter treated but gives fairly predictable placement; a cell suspension can cover a proportionally larger recipient area from the same donor site but spreads more diffusely as the cells migrate and multiply across the treated skin.

What Happens During and After the Procedure

The donor site, usually skin unaffected by vitiligo, is prepared and the graft material is transferred to the depigmented recipient area, which is typically dressed and protected while the graft takes and new pigment begins spreading outward from the transplanted cells 2Ref 2National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024).Vitiligo.Vitiligo is a chronic autoimmune disorder in which melanocytes are destroyed, causing depigmented patches, with no cure but treatments that can stabilize and repigment skin; basis for the definitional framing and for why surgery requires melanocyte-destroying activity to have quieted first.. Full results take time to appear. Pigment doesn't show up immediately, and it can take weeks to months for a graft to visibly repigment the surrounding skin.

A common early cobblestone-like texture at the graft site tends to smooth out as healing continues, though this varies by technique and by how the wound is cared for during recovery.

Both the donor and recipient sites need protection from sun exposure and friction while healing, since the donor site is itself a fresh wound and can scar or, less commonly, lose pigment if it isn't cared for well. Follow-up visits over the following months let the treating dermatologist track how much of the recipient area has repigmented and whether a touch-up procedure or additional phototherapy would help finish the job.

Why Surgery Is Often Paired With Light or Topical Treatment After

Grafted melanocytes need a stimulus to migrate outward and repigment the surrounding skin, and narrowband UVB phototherapy after surgery is commonly used for exactly that purpose, building on the same mechanism that makes phototherapy effective as a standalone treatment 1Ref 1Bae JM, Jung HM, Hong BY, et al. (2017).Phototherapy for Vitiligo: A Systematic Review and Meta-analysis.Narrowband UVB phototherapy produces meaningful repigmentation in vitiligo, with response increasing over months of treatment; basis for phototherapy as a first-line treatment tried before surgery and as a common adjunct used to help grafts repigment surrounding skin.. Some clinicians also use a topical treatment such as ruxolitinib cream after grafting to support repigmentation at the graft margins, extending an approach shown to help drive facial and body repigmentation on its own in clinical trials 3Ref 3Rosmarin D, Passeron T, Pandya AG, et al. (2022).Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.Topical ruxolitinib cream produces significantly greater facial and total-body repigmentation than vehicle in nonsegmental vitiligo; basis for ruxolitinib as a treatment tried before surgery and used as a post-graft adjunct to support repigmentation..

This combination approach, surgery to place new pigment cells, then light or topical treatment to help that pigment spread, reflects that grafting alone places cells in the right location but doesn't by itself guarantee they'll spread as far as hoped.

The timing of that follow-up treatment, how soon after surgery it starts and how long it continues, is generally individualized to how the graft is healing, and it's a conversation to have with the treating dermatologist before the procedure rather than something to figure out afterward.

Realistic Expectations, by Location and Skin Type

Results vary considerably by where the graft is placed: the face and trunk generally repigment more reliably than the hands and feet, which are known among clinicians as some of the hardest areas to treat successfully with any vitiligo approach, surgical or otherwise. Matching skin tone between the graft and surrounding area isn't guaranteed either, and a small risk of scarring, texture change, or the graft simply not taking exists with every technique.

A graft that doesn't fully take or match isn't necessarily a failed procedure end to end. A dermatologist experienced in vitiligo surgery can often assess whether a second, smaller procedure or additional phototherapy is a reasonable next step.